Psychotomimetics. Chemical, pharmacological and clinical aspects. 1961

A HOFMANN

UI MeSH Term Description Entries
D006213 Hallucinogens Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. Hallucinogen,Hallucinogenic Agent,Hallucinogenic Drug,Hallucinogenic Substance,Psychedelic,Psychedelic Agent,Psychedelic Agents,Psychotomimetic Agent,Psychotomimetic Agents,Hallucinogenic Agents,Hallucinogenic Drugs,Hallucinogenic Substances,Psychedelics,Agent, Hallucinogenic,Agent, Psychedelic,Agent, Psychotomimetic,Agents, Hallucinogenic,Agents, Psychedelic,Agents, Psychotomimetic,Drug, Hallucinogenic,Drugs, Hallucinogenic,Substance, Hallucinogenic,Substances, Hallucinogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A HOFMANN
January 2011, Molecules (Basel, Switzerland),
A HOFMANN
November 2004, Chemistry & biodiversity,
A HOFMANN
December 2000, Current medicinal chemistry,
A HOFMANN
March 1972, Revista medica de Chile,
A HOFMANN
December 2008, Expert opinion on drug metabolism & toxicology,
A HOFMANN
January 1972, Acta obstetricia et gynecologica Scandinavica. Supplement,
A HOFMANN
July 2020, Antioxidants (Basel, Switzerland),
A HOFMANN
June 2011, Natural product communications,
Copied contents to your clipboard!